Please login to the form below

Not currently logged in
Email:
Password:

New executive at PhRMA

Pharmaceutical Research and Manufacturers of America, the industry's main US trade group, has confirmed former IBM executive Rod Hunter as the organisation's new senior vice president of international advocacy

Pharmaceutical Research and Manufacturers of America (PhRMA), the industry's main US trade group, has confirmed former IBM executive Rod Hunter as the organisation's new senior vice president of international advocacy, effective June 10.

Hunter will be responsible for leading and overseeing PhRMA's international advocacy functions, reporting to executive vice president of advocacy Chip Davis.

At IBM, Hunter served as vice president, governmental programmes, Europe. Earlier in his career, he served as special assistant to the president and senior director of the White House's National Security Council under President George W Bush, coordinating the administration's international economic agenda, including trade, intellectual property, investment, energy and environmental policies.

"With his broad international trade experience in both the private and public sectors, Rod brings to bear a keen understanding of the complex policies and market dynamics inherent to an increasingly global economy," Davis said in a statement.

13th May 2011

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Cuttsy + Cuttsy

How do you understand what patients really need, without actually living their lives? How do you walk in someone else’s...

Latest intelligence

Robust Review: COVID19 Assessment
See how our client utilized Rapid Payer Response (RPR) to stay informed and gain continuous insights during the recent global pandemic (COVID19)...
Human behaviour - Sept 21
All change – how untangling human behaviour can encourage better health
Driving better patient outcomes through clear, achievable practical steps that are underpinned by transparent evidence...
Health literacy in the time of COVID-19
In a time when much of the media’s focus is on the ongoing COVID-19 pandemic and the differences in vaccination rates between various regions, countries, and socioeconomic groups, improving health...